Search clinical trials for: Daratumumab Hyaluronidase-fihj
Total 441 results
-
Memorial Sloan Kettering Cancer CenterTrillium Therapeutics Inc.Active, not recruitingMultiple MyelomaUnited States
-
Georgetown UniversityJanssen, LPRecruitingMonoclonal Gammopathy of Undetermined Significance | Peripheral NeuropathyUnited States
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma (RRMM)United States, Canada
-
Barry A. BoilsonJanssen Biotech, Inc.Enrolling by invitation
-
Thomas Jefferson UniversityJanssen Scientific Affairs, LLCActive, not recruitingPlasma Cell MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; Janssen Pharmaceuticals; Multiple Myeloma Research ConsortiumRecruitingMultiple MyelomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Janssen Research & Development, LLCNot yet recruitingLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Myelofibrosis | Non Hodgkin Lymphoma | Chronic Myeloid Leukemia | Hematologic Malignancy | Aplastic Anemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Bone Marrow Transplant Rejection | Acute Lymphoblastic Leukemia (ALL), Adult
-
Dartmouth-Hitchcock Medical CenterActive, not recruitingHemolytic AnemiaUnited States
-
NYU Langone HealthRecruitingNon-small Cell Lung Cancer With STK11/LKB1 MutationUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Spain, Netherlands, Sweden, Denmark, France
-
Eastern Cooperative Oncology GroupJanssen, LPRecruitingT-cell Acute Lymphoblastic LeukemiaUnited States
-
Abdullah KhanTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
Nanjing University School of MedicineRecruiting
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
National Cancer Institute (NCI)Recruiting
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Bausch & Lomb IncorporatedCompletedDiabetic Retinopathy | Vitreous HemorrhageUnited States, Canada, Mexico
-
Bausch & Lomb IncorporatedCompleted
-
Brigham and Women's HospitalWithdrawnMorphea | Scleroderma | CREST Syndrome | Microstomia | Scleromyxedema
-
Bausch & Lomb IncorporatedCompleted
-
Bausch & Lomb IncorporatedCompletedDiabetic Retinopathy | Vitreous DetachmentUnited States
-
University of NebraskaRecruiting
-
Halozyme TherapeuticsBaxter Healthcare CorporationCompleted
-
Vanderbilt University Medical CenterBaxter Healthcare CorporationCompletedDehydration | Pediatrics | Cardiac OutputUnited States
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
Halozyme TherapeuticsBaxter Healthcare CorporationCompleted
-
BMI KoreaCompletedHealth, SubjectiveKorea, Republic of
-
Marc L Gordon, MDJanssen Scientific Affairs, LLCCompletedAlzheimer DiseaseUnited States
-
Hoffmann-La RocheCompletedMultiple MyelomaUnited States, Australia, United Kingdom
-
Boston Medical CenterJanssen PharmaceuticalsCompleted
-
Johns Hopkins UniversityRecruiting
-
Northwestern UniversityActive, not recruiting
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedLymphedema | Malignant NeoplasmUnited States
-
Steve Yoelin M.D. Medical Associates, Inc.Completed
-
University of ArkansasJanssen Scientific Affairs, LLCRecruiting
-
Incyte CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany
-
Ostfold Hospital TrustOdense University Hospital; Oslo University Hospital; Haukeland University Hospital and other collaboratorsActive, not recruiting
-
Ronald WittelesCompletedHeart Transplant Failure and Rejection | AllosensitizationUnited States
-
Eisai Inc.Halozyme TherapeuticsTerminated
-
Institute of Hematology & Blood Diseases HospitalNot yet recruiting
-
Corvus Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Charite University, Berlin, GermanyJanssen-Cilag G.m.b.H; Labor Berlin-Charité Vivantes G.m.b.H; Deutsches Rheuma-Forschungszentrum... and other collaboratorsNot yet recruiting
-
National Cancer Institute (NCI)RecruitingLymphoma, Primary EffusionUnited States
-
Massachusetts General HospitalBaxter Healthcare CorporationCompletedDehydration | Mass Casualty IncidentUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
Assistance Publique - Hôpitaux de ParisJanssen, LPCompletedKidney Transplant Rejection | Antibody-mediated Rejection | AllosensitizationFrance
-
Hoag Memorial Hospital PresbyterianRecruiting